Perhaps the most critical aspect of Moderna's business to pay attention to right now is its late-stage pipeline. The company ...

In this episode of the Applied Clinical Trials Brief, we recap our three most-viewed stories of the previous week with a look into the FDA’s heightened scrutiny of trial design, the wind-down of ...